INTRODUCTION
Alzheimer's disease (AD) is the most common form of human amyloidosis and is characterized by the presence of extracellular amyloid deposits in both the cerebral neuropil and in meningeal and cerebrocortical blood vessels. The 40 and 42 amino acid amyloid ␤-proteins (A␤) are major components of these deposits. Because A␤ is produced continuously by cells in the nervous system as well as in peripheral tissues (Haass et al., 1992) and is found in the CSF and plasma of both normal individuals and AD patients (Shoji et al., 1992; Seubert et al., 1992; Scheuner et al., 1996) , the source of A␤ that contributes to this deposition needs to be identified to facilitate our understanding of the molecular mechanisms of AD, as well as to identify therapeutic targets.
To determine the extent to which A␤ in brain parenchyma could be derived from peripheral sources in AD and during normal brain aging, the permeability of the various A␤ species at the blood-brain barrier
